4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-22-006321
Chief Development Officer sold 2,043 shares at an average $3.69 ($7,545)
From the SEC's structured data for this filing
Trades in this filing
LeBel Carl · Chief Development Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-18 | Sale : show line 1 in the form | −974 | $3.87 | $3,772 | 12,195 | D |
| 2022-02-22 | Sale : show line 2 in the form | −1,069 | $3.53 | $3,773 | 11,126 | D |
| Open-market sales · 2,043 sh · avg $3.69 · $7,545 | ||||||
Loading xslF345X03/form4.xml…